The Slow Newscast
The immortality bros: The business of living forever
Dec 17, 2024
Dive into the intriguing world of biohacking as tech entrepreneurs seek to reverse aging in a libertarian haven. Discover the extreme lengths some will go, like blood transfusions from younger donors, to achieve immortality. The risks of gene therapy in unregulated zones raise ethical questions about the future of biotechnology. With disillusionment in conventional science, innovators navigate the controversial landscape of self-experimentation, opening a dialogue on the moral implications of profit-driven health advancements.
44:13
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Brian Johnson's radical anti-aging journey illustrates the rise of biohacking, merging self-experimentation with unregulated medical practices in pursuit of longevity.
- The controversy surrounding Prospera highlights ethical concerns regarding the commercialization of experimental treatments, raising questions about safety, accountability, and informed consent.
Deep dives
The Quest for Anti-Aging
Brian Johnson, a 47-year-old entrepreneur, has committed to a radical anti-aging regimen that blurs the lines between science and self-experimentation. He aims to reverse his biological age, which he claims has reached 42.5 according to specific measurements, by investing $2 million annually in a variety of treatments and protocols. Among these is gene therapy at a clinic in Prospera, a deregulated zone in Honduras, where he views this groundbreaking experiment as a step towards defying death. His journey has made waves on social media, positioning him as a prominent figure among biohackers while challenging conventional boundaries of modern medicine and longevity research.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
